Literature DB >> 16516668

Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).

Sean Whittaker1.   

Abstract

Mycosis fungoides and Sezary syndrome, collectively known as cutaneous T-cell lymphomas (CTCLs), are low-grade, indolent, clonal, non-Hodgkin's lymphomas consisting of CD4+ CD45RO+ T cells with a CLA+ CCR4+ skin-homing phenotype. There are several variants of primary CTCLs with differences in clinical behavior and prognosis. Currently, the precise etiologies of mycosis fungoides and Sezary syndrome are unknown. This article reviews our current understanding of the pathogenetic abnormalities involving genomic mutations, abnormal cDNA expression, and dysregulation of signaling pathways in CTCL.

Entities:  

Mesh:

Year:  2006        PMID: 16516668     DOI: 10.1053/j.seminoncol.2005.12.015

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  5 in total

1.  The Histological Spectrum of Early Mycosis Fungoides: A Study of 58 Saudi Arab patients.

Authors:  Maha Arafah; Shaesta Naseem Zaidi; Hala Kassouf Kfoury; Ammar Al Rikabi; Khalid Al Ghamdi
Journal:  Oman Med J       Date:  2012-03

2.  Multicenter phase II trial of temozolomide in mycosis fungoides/sezary syndrome: correlation with O⁶-methylguanine-DNA methyltransferase and mismatch repair proteins.

Authors:  Christiane Querfeld; Steven T Rosen; Joan Guitart; Alfred Rademaker; David S Pezen; M Eileen Dolan; Joseph Baron; Daniel B Yarosh; Francine Foss; Timothy M Kuzel
Journal:  Clin Cancer Res       Date:  2011-07-11       Impact factor: 12.531

3.  Increased Twist expression in advanced stage of mycosis fungoides and Sézary syndrome.

Authors:  Meghali Goswami; Madeleine Duvic; Alexis Dougherty; Xiao Ni
Journal:  J Cutan Pathol       Date:  2012-05       Impact factor: 1.587

4.  Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.

Authors:  Anjali Mishra; Krista La Perle; Sonya Kwiatkowski; Laura A Sullivan; Gregory H Sams; Jessica Johns; Douglas P Curphey; Jing Wen; Kathleen McConnell; Jun Qi; Henry Wong; Giandomenico Russo; Jianying Zhang; Guido Marcucci; James E Bradner; Pierluigi Porcu; Michael A Caligiuri
Journal:  Cancer Discov       Date:  2016-07-15       Impact factor: 39.397

5.  Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.

Authors:  Urs B Hagemann; Lavinia Gunnarsson; Solène Géraudie; Ulrike Scheffler; Remko A Griep; Herald Reiersen; Alexander R Duncan; Sergej M Kiprijanov
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.